Covariates in Pharmacometric Repeated Time-to-Event Models: Old and New (Pre)Selection Tools Sebastiaan C. GouloozeElke H. J. KrekelsCatherijne A. J. Knibbe Research Article Open access 18 December 2018 Article: 11
Golimumab Dried Blood Spot Analysis (GOUDA): a Prospective Trial Showing Excellent Correlation with Venepuncture Samples and More Detailed Pharmacokinetic Information Iris DetrezGanel SchopsAnn Gils Research Article 18 December 2018 Article: 10
Measurement of IL-17AA and IL-17FF as Pharmacodynamic Biomarkers to Demonstrate Target Engagement in the Phase I Study of MCAF5352A Kun PengYehong WangTracy L. Staton Research Article 13 December 2018 Article: 9
PBPK and its Virtual Populations: the Impact of Physiology on Pediatric Pharmacokinetic Predictions of Tramadol Huybrecht T’jollynAn VermeulenJan Van Bocxlaer Research Article 29 November 2018 Article: 8
The Assessment of Quality Attributes for Biosimilars: a Statistical Perspective on Current Practice and a Proposal Johanna MielkeFranz InnerbichlerByron Jones Research Article 27 November 2018 Article: 7
Overlooked Issues on Pharmacokinetics Data Interpretation of Protein Drugs—a Case Example of Erythropoietin Guohua AnRobert L. SchmidtJohn A. Widness Brief/Technical Note 26 November 2018 Article: 6
Effect of the Plasticizer DEHP in Blood Collection Bags on Human Plasma Fraction Unbound Determination for Alpha-1-Acid Glycoprotein (AAG) Binding Drugs Nicholas IngramChristopher DishingerMichael Huskin Research Article 16 November 2018 Article: 5
Approaches to Resolve False Reporting in Neutralizing Antibody Assays Caused by Reagent Leaching from Affinity Capture Elution Solid Phase Yuhong XiangJohn KamerudBoris Gorovits Research Article 06 November 2018 Article: 4
In Vitro and In Vivo Efficacy of the Monocarboxylate Transporter 1 Inhibitor AR-C155858 in the Murine 4T1 Breast Cancer Tumor Model Xiaowen GuanMark A. BryniarskiMarilyn E. Morris Research Article 05 November 2018 Article: 3
The Journey to AAPS 2020: a Reflection from Strategic Planning to PharmSci 360 Joseph W. PolliChristopher R. McCurdyfor the AAPS Leadership Editorial 03 November 2018 Article: 2
Population Pharmacokinetics of AL-335 and Its Two Main Metabolites (ALS-022399, ALS-022227) in Monotherapy and in Combination with Odalasvir and/or Simeprevir Elodie ValadeThomas N. KakudaOliver Ackaert Research Article 24 October 2018 Article: 1